Clinical Trials Directory

Trials / Conditions / Metastatic Thyroid Gland Carcinoma

Metastatic Thyroid Gland Carcinoma

8 registered clinical trials studyying Metastatic Thyroid Gland Carcinoma — 1 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingLenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Met
NCT04171622
M.D. Anderson Cancer CenterPhase 2
RecruitingCryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, t
NCT04693377
M.D. Anderson Cancer CenterN/A
WithdrawnPembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer
NCT04731740
Saint Petersburg State University, RussiaPhase 2
Active Not RecruitingEncorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refract
NCT04061980
Providence Health & ServicesPhase 2
Active Not RecruitingAtezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer
NCT03181100
M.D. Anderson Cancer CenterPhase 2
CompletedIodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
NCT02393690
Academic and Community Cancer Research UnitedPhase 2
Active Not RecruitingTrametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
NCT02152995
National Cancer Institute (NCI)Phase 2
Active Not RecruitingDabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery
NCT01947023
National Cancer Institute (NCI)Phase 1